Abstract
Introduction: Tumor-Infiltrating Lymphocytes (TILS) is a well-known predictor of response to primary chemotherapy1,2 and a good prognostic factor for survival in breast different subtypes3. In SABCC20214 we presented data on the relationship between TILs cut-off 20% and pCR (15.6% vs 41.4%, p = 0.0001). In the present study we have analyzed the association of the level of TILs cut-off 20% and survival in the different molecular subtypes at 5 and 10 years.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call